Eltrombopag
Top View
- PDL DRUG REVIEW Proprietary Name: Zeposia® Common Name: Ozanimod PDL Category: Multiple Sclerosis Agents
- Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
- NEW 2018 Specialty Drugs
- The Effect of Eltrombopag in Managing Thrombocytopenia Associated With
- Lumicera Specialty Drug List
- Brand Generic Guide
- Proposed Formulary Changes Effective 4-1-2019 (Unless Otherwise Noted)
- 07 Poster Viewing I 65..65
- The Role of Eltrombopag and Romiplostim As The
- Effect of Cytokine Gene Polymorphisms on Eltrombopag Reactivity in Japanese Patients with Immune Thrombocytopenia
- PROMACTA (Eltrombopag) RATIONALE for INCLUSION IN
- Immunosuppression and Growth Factors for Severe Aplastic Anemia: New Data for Old Questions David J
- Eltrombopag (Revolade) for Severe Aplastic Anaemia – First Line
- Drug Safety Update
- Pharmacy Specialty Drug Policies
- The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
- JAKAFI® Or PROMACTA®
- Successful Treatment of Secondary Poor Graft Function Post Allogeneic